voriconazole
Generic: voriconazole
Labeler: amneal pharmaceuticals llcDrug Facts
Product Profile
Brand Name
voriconazole
Generic Name
voriconazole
Labeler
amneal pharmaceuticals llc
Dosage Form
POWDER, FOR SUSPENSION
Routes
Active Ingredients
voriconazole 40 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
65162-913
Product ID
65162-913_b09170c8-4ca1-4e5e-9c29-cbb36a3f585d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA205034
Listing Expiration
2027-12-31
Marketing Start
2013-11-29
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65162913
Hyphenated Format
65162-913
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
voriconazole (source: ndc)
Generic Name
voriconazole (source: ndc)
Application Number
ANDA205034 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 40 mg/mL
Packaging
- 75 mL in 1 BOTTLE (65162-913-22)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b09170c8-4ca1-4e5e-9c29-cbb36a3f585d", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "unii": ["JFU09I87TR"], "rxcui": ["465355"], "spl_set_id": ["ed6624a9-0b73-4a21-bf13-a8add2081d02"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "75 mL in 1 BOTTLE (65162-913-22)", "package_ndc": "65162-913-22", "marketing_start_date": "20131129"}], "brand_name": "Voriconazole", "product_id": "65162-913_b09170c8-4ca1-4e5e-9c29-cbb36a3f585d", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "65162-913", "generic_name": "Voriconazole", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Voriconazole", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "40 mg/mL"}], "application_number": "ANDA205034", "marketing_category": "ANDA", "marketing_start_date": "20131129", "listing_expiration_date": "20271231"}